| 1 | Ordinary | Adoption of standalone and consolidated financial statements for the year ended 31 March 2024 |  |
| 2 | Ordinary | Reappoint Huzaifa Khorakiwala (DIN: 02191870) as Director, liable to retire by rotation |  |
| 3 | Ordinary | Appoint M S K C & Associates, as statutory auditors for five years from the date of the AGM and fix their remuneration at Rs. 13 mn annually | |
| 4 | Ordinary | Approve remuneration of Rs. 335,000 for Kirit Mehta & Co.as cost auditors for FY25 | |
| 5 | Ordinary | Approve related party transactions between Wockhardt Limited (Wockhardt) and Wockhardt Bio AG, Switzerland (WBA) and WBA’s subsidiaries, WBA and its own subsidiaries, upto USD 500 mn annually, and between Wockhardt and Khorakiwala Holdings and Investments Private Ltd (KHIPL) upto Rs. 15 bn | |
| 6 | Special | Reappoint Habil Khorakiwala (DIN: 00045608) as Executive Chairperson Director, not liable to retire by rotation, for five years from 1 March 2025 and fix his remuneration as minimum remuneration, capped at Rs. 50 mn | |
| 7 | Special | Appoint Ahmad Javed (DIN: 08668304) as Independent Director for five years 28 May 2024 | |
| 8 | Special | Issue equity shares or equity-linked securities upto Rs.10.0 bn | |
June 28, 2024, 11 a.m.